Literature DB >> 31584624

α-Actinin-4 regulates cancer stem cell properties and chemoresistance in cervical cancer.

Jaeyeon Jung1, Suhyun Kim1, Hyoung-Tae An1, Jesang Ko1.   

Abstract

Cancer stem cells (CSCs) initiate tumors and possess the properties of self-renewal and differentiation. Since they are responsible for chemoresistance, CSCs are known to be a key factor in cancer recurrence. α-Actinin-4 (ACTN4) is an actin-binding protein that is involved in muscle differentiation and cancer metastasis. It promotes epithelial to mesenchymal transition and cell cycle progression via β-catenin stabilization in cervical cancer. In the present study, we investigated the role of ACTN4 in regulating cancer cell stemness and chemoresistance in cervical cancer. Results from the gene expression database analysis showed that ACTN4 mRNA expression was elevated in cancerous cervices when compared with normal cervices. Furthermore, ACTN4 knockdown suppressed sphere formation and CSC proliferation. It also decreased CSC size and CD44high/CD24low cell population. ACTN4-knockdown CSCs were sensitive to anticancer drugs, which was observed by down-regulation of the ATP-binding cassette family G2 involved in drug resistance. Finally, ACTN4-knockdown CSCs formed reduced tumors in vivo when compared with control CSCs. Overall, these findings suggest that ACTN4 regulates CSC properties and contributes to chemoresistance in cervical cancer.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Year:  2020        PMID: 31584624     DOI: 10.1093/carcin/bgz168

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  7 in total

1.  RNF38 suppress growth and metastasis via ubiquitination of ACTN4 in nasopharyngeal carcinoma.

Authors:  Cheng Lin; Meifang Li; Na Lin; Jingfeng Zong; Jianji Pan; Yunbin Ye
Journal:  BMC Cancer       Date:  2022-05-15       Impact factor: 4.638

2.  Combined Detection of ACTN4 and SCC-Ag is a Promising Serological Biomarker for Cervical Intraepithelial Neoplasia 3 or Worse: A Case-Control Study.

Authors:  Bin Zhu; Binhua Dong; Simei Hong; Meihua Wang; Weichao Dai; Qingzhu Zheng; Dan Wu; Yingping Cao
Journal:  Risk Manag Healthc Policy       Date:  2020-11-20

Review 3.  The role of polyphenols in overcoming cancer drug resistance: a comprehensive review.

Authors:  Parisa Maleki Dana; Fatemeh Sadoughi; Zatollah Asemi; Bahman Yousefi
Journal:  Cell Mol Biol Lett       Date:  2022-01-03       Impact factor: 5.787

Review 4.  Involvement of Actin and Actin-Binding Proteins in Carcinogenesis.

Authors:  Magdalena Izdebska; Wioletta Zielińska; Marta Hałas-Wiśniewska; Alina Grzanka
Journal:  Cells       Date:  2020-10-06       Impact factor: 6.600

Review 5.  The long and short non-coding RNAs modulating EZH2 signaling in cancer.

Authors:  Sepideh Mirzaei; Mohammad Hossein Gholami; Kiavash Hushmandi; Farid Hashemi; Amirhossein Zabolian; Israel Canadas; Ali Zarrabi; Noushin Nabavi; Amir Reza Aref; Francesco Crea; Yuzhuo Wang; Milad Ashrafizadeh; Alan Prem Kumar
Journal:  J Hematol Oncol       Date:  2022-03-02       Impact factor: 17.388

6.  LncRNA TP73-AS1 Exacerbates the Non-Small-Cell Lung Cancer (NSCLC) Process via Regulating miR-125a-3p-Mediated ACTN4.

Authors:  Yueyang Tong; Zhemin Feng; Yaqian Li; Chenxi Yan; Wenbo He; Xueyuan Chen
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-09       Impact factor: 2.650

Review 7.  The Expressions and Mechanisms of Sarcomeric Proteins in Cancers.

Authors:  Xiaojing Yang; Hanru Ren; Xiaomao Guo; Chaosu Hu; Jie Fu
Journal:  Dis Markers       Date:  2020-06-30       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.